Neoadjuvant Radiotherapy for Soft Tissue Sarcoma
Volume 9 - Issue 1
Sam Hajialiloo Sami1, Azra Izanloo2, Arefpoor Amir Mohamad3 and Mirkazemi Masoud*1
-
Author Information
Open or Close
- 1Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, IR Iran.
- 2Razavi Cancer Research Center, Razavi Hospital, Imam Reza International University, Mashhad, Iran
- 3Firrozgar Hospital, Iran University of Medical Sciences, Iran
*Corresponding author:
Masoud Mirkazemi, Bone and Joint Reconstruction Research Centre, Shafa Orthopaedic Hospital, Iran University of Medical Sciences, Tehran, Iran
Received: September 08, 2018; Published: September 18, 2018
DOI: 10.26717/BJSTR.2018.09.001753
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Soft Tissue Sarcoma (STS) is a rare neoplasm that accounts for 1% of all solid tumors in adults. In 2013, 11410 new cases were diagnosed in adults and children in the United States with 4,390 expected deaths [1].
Mini Review |
References |